CMMB Latest Press Releases

-- March 19, 2026 --

Chemomab Therapeutics Announces Year End and Fourth Quarter 2025 Financial Results and Provides a Corporate Update Globe Newswire 8:00 AM

-- February 17, 2026 --

Chemomab Therapeutics to Participate in Oppenheimer 36th Annual Healthcare Life Sciences Conference Globe Newswire 8:00 AM

-- December 2, 2025 --

Chemomab Therapeutics Announces Nebokitug Phase 2 SPRING Trial Results in Primary Sclerosing Cholangitis Published in the American Journal of Gastroenterology Globe Newswire 8:00 AM

-- November 24, 2025 --

Chemomab to Participate in Oppenheimer's Movers in Rare Disease Summit Globe Newswire 8:00 AM

-- November 20, 2025 --

Chemomab Therapeutics Announces Third Quarter 2025 Financial Results and Provides Corporate Update Globe Newswire 8:00 AM

-- November 6, 2025 --

Chemomab Announces Multiple Presentations at AASLD The Liver Meeting 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software